United States · FDA National Drug Code directory
Topiramate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76282-281_9c981813-533d-40b5-b9ea-5648dd7c7da0
- Product NDC
- 76282-281
- Form
- TABLET
- Composition / generic term
- Topiramate
- Labeler
- EXELAN PHARMACEUTICALS INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200907
- Source listing expiry
- 20261231
Source-listed ingredients
- TOPIRAMATE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET in 1 BOTTLE (76282-281-10) · 76282-281-10
- 60 TABLET in 1 BOTTLE (76282-281-60) · 76282-281-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →